Rheumaderm : Current Issues in Rheumatology and Dermatology

The disciplines of rheumatology and dermatology are involved in the care of several diseases that share cutaneous and locomotor as well as, quite often, systemic involvement. While traditionally remaining separate, it has long been recognized that there are several areas of common interest in these two specialties. Indeed, this had been realized by sev­ eral far-sighted physicians, both rheumatologists and dermatologists, such asG. Rodnan and 1. Gilliam. A number of books have been published over the past few years specifi­ cally dealing with skin involvement in the connective tissue diseases, both inherited and acquired. These include The Skin in Rheumatic Disease, by C. R. Lovell, P. 1. Maddison, and G. V. Campion (Chapman and Hall Medical, 1990), Connective Tissue Diseases o(the Skin, edited by C. M. Lapiere and T. Krieg (Marcel Dekker, Inc. 1993), and Cutaneous Manifestations of Rheumatic Diseases, edited by R. D. Sontheimer and T. T. Provost (Wil­ liams and Wilkins, 1996). However, despite this shared interest, meetings combining the two specialties were generally limited to small interest groups. It had long been felt that a workshop should be organized that could bring together the views of specialists from the two areas and focus on the challenges that this common ground brings to these two disciplines.

1. The Interface between Rheumatology and Dermatology: Why Rheumaderm?.- 2. Nature and Nurture in Systemic Lupus Erythematosus.- 3. Heritable Connective Tissue Disorders.- 4. Neonatal Lupus Erythematosus.- 5. Prognosis in Juvenile Arthritis.- 6. Scleroderma in Children.- 7. Localized Morphea in Children.- 8. Autoimmune Thyroid Disorders in Juvenile Chronic Arthritis and Systemic Lupus Erythematosus.- 9. Prevalence of IgM-, IgA- and IgG-Rheumatoid Factors in Seronegative Polyarticular Disease Compared to Pauciarticular Disease in Juvenile Chronic Arthritis as Measured by ELISA.- 10. Incidence and Outcome of Kawasaki Disease in Malta.- 11. Systemic Sclerosis: AClinical Overview.- 12. Scleroderma Overlap Syndromes.- 13. Raynaud’s Phenomenon and Vascular Disease in Systemic Sclerosis.- 14. Linear Scleroderma en Coup de Sabre: Relationship with Progressive Facial Hemiatrophy (PFH).- 15. Scleroderma Profunda: Clinicopathological Studies.- 16. Early Diagnosis of Systemic Sclerosis.- 17. Cutaneous Necrotizing Vasculitis: Relation to Systemic Disease.- 18. Sjögren’s Syndrome: Autoimmune Epithelitis.- 19. Behçet’s Syndrome: The Cerrahpasa Experience H. Yazici and the Members of the Behçet’s Syndrome Research Centre.- 20. Autoantibodies in SLE: Disease Associations.- 21. Polymorphisms of the Xenobiotic-Metabolizing Enzymes CYP1A1 and NAT-2 in Systemic Sclerosis and Lupus Erythematosus.- 22. Elevated Soluble E-Selectin in Cutaneous Lupus Erythematosus.- 23. RNP Positivity in Maltese SLE Patients.- 24. Chilblain Lupus Erythematosus Is Associated with Antibodies to SSA/Ro.- 25. Male SLE Patients in Malta.- 26. Dermatomyositis: Diagnosis and Evaluation of Dermatomyositis, Polymyositis, Inclusion-Body Myositis.- 27. Dermatomyositis and Drugs.- 28. Dermatomyositis Associated with Malignancy: 12 Case Reports.- 29. Reactive Arthritis.- 30. Psoriatic Arthritis: Is Something Changing?.- 31. Incidence of Antiperinuclear Factor in Patients with Psoriatic Arthritis.- 32. Triggered Psoriasis.- 33. Pyridinium Crosslinks Excretion in Patients with Rheumatoid Arthritis: Correlation with Disease Activity and Glucocorticoid Treatment.- 34. Porphyria: From Sir Walter Raleigh to Molecular Biology.- 35. Photosensitivity and Joint Dysfunction.- 36. Role of Superantigens in Dermatology.- 37. Intravascular Lymphomatosis: A Report of Ten Patients with Central Nervous System Involvement and a Review of the Disease Process.- 38. Pemphigus and Diet: Have We Solved the Mystery of Fogo Selvagem?.- 39. The Treatment of Systemic Sclerosis.- 40. Enalapril (10 Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): Echocardiographic Substudy—Three Months Follow-Up..- 41. Enalapril (10 Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): ECG Exercise Testing—Three Months Follow-Up.- 42. Enalapril (10 Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): Pulmonary Substudy—Effects of Three Month Treatment.- 43. Enalapril (10Mg/Day) in Systemic Sclerosis: One Year, Double Blind, Randomised Study (ESS-1): Electrocardiographic Substudy—Three Months Follow-Up,.- 44. Treatment of Generalized Morphea with Oral 1.25- Dihydroxyvitamin D3.- 45. Vasospasmolytic Therapy in Patients with SSC.- 46. Biomechanical Stimulation Therapy: A Novel Physiotherapy Method for Systemic Sclerosis.- 47. Reduced Skin Stiffness by Grenz Ray Treatment in Generalized Morphea.- 48. NSAIDs/Corticosteroids—Primum Non Nocere.- 49. Management Issues in Vasculitis.- 50. Sulphasalazine: An Alternative Drug for Second-Line Treatment of Juvenile Chronic Arthritis.- 51. Cyclosporin A and Retinoids in Psoriasis.- 52. Methotrexate.- 53. Azathioprine in Dermatological Practice: An Overview with Special Emphasis on Its Use in Non-Bullous Inflammatory Dermatoses.- 54. The Effect of Methylprednisolone Pulse Therapy in Polymyositis/ Dermatomyositis.- 55. Toxicity Profile of Methotrexate in Rheumatoid Arthritis: A Preliminary Survey.- 56. Mucocutaneous Side Effects and Continuation of Aurotherapy in Patients with Rheumatoid Arthritis.- 57. Discoid Lupus Erythematosus Lesions Treated with Cryosurgery.- 58. The Value of Colloid Dressings in Psoriasis.- 59. Antibiotic Resistance in Bacteria: A Current and Future Problem.- 60. Newer Concepts in Antimicrobial Therapy.- 61. Anecdotal Therapies.- 62. Chondrocytes-ECM Interactions in Human Osteoarthritis.- 63. The Inverse Relationship between Osteoporosis and Osteoarthritis.- 64. Osteoarthritis: New Challenges in an Old Disease.- 65. Increased Reduction in Bone Density and Skin Thickness in Postmenopausal Women on Long Term Corticosteroid Therapy: A Suggested Role for Estrogen Add Back Therapy.- 66. Paget’s Disease of Bone in Malta: A Preliminary Survey.- 67. Joint Replacement: The Final Solution?.- 68. The Archaeology of Joint Disease.- 69. Sun and Skin: Role of Phototype and Skin Colour.- 70. Topical Retinoids in the Treatment of Aging of the Skin.- 71. Carbon Dioxide Laser Resurfacing of the Aged Face.- 72. Melasma.- 73. Skin Tumours in Prematurely Photoaged Skin after Long-Term Immunosuppression Treated with CO2 Laser.- 74. An Overview of Classic Kaposi’s Sarcoma in Greece.- 75. Surface Evaluation of Living Skin.- 76. Raynaud’s Phenomenon Caused by Giant Cell Arteritis: A Case Report.- 77. Accelerated Nodulosis during Methotrexate Therapy for Refractory Rheumatoid Arthritis: A Case Report.- 78. Rheumatoid Vasculitis Associated with Anticardiolipin Antibodies.- 79. Unilateral Proptosis in a 74-Year-Old Woman.- 80. Naevus Varicosus Osteohypertrophicus: An Early Diagnostic Approach.- 81. Pyoderma Gangrenosum Successfully Treated with Cyclosporin A.- 82. Cardiac Involvement and Left Ventricular Failure in a Patient with the Churg—Strauss Syndrome.- 83. Plectin Deficiency Disease: A Case Report.- 84. Toxic Epidermal Necrolysis in a Patient with Psoriatic Arthritis.